TLR7 and neoplasm: Similarly, an impressive systemic anti-tumor immune response was elicited by irreversible electroporation (IRE) of local PDAC tumors that were co-treated with an intratumoral TLR7 agonist (1V270) and systemic anti-PD-1 receptor checkpoint blockade.